Home » Newsletters » BioWorld Science

BioWorld Science

April 1, 2014

View Archived Issues

Hydrogel-based inhibitor delivery system developed to prevent adverse cardiac remodeling

Roche divulges new agents for HBV infection

Idera Pharmaceuticals reports topline data from phase II trial of IMO-8400

Fujifilm and Center for iPS Cell Research initiate collaboration on T-817MA

Amgen presents new GK-GKRP disruptors for type 2 diabetes

Quidel receives FDA clearance for AmpliVue HSV 1+2 assay

Meridian Biosciences' illumigene Pertussis test cleared by the FDA

FDA committee recommends approval of Cologuard colorectal cancer screening test

Japan Vaccine seeks approval of pediatric pneumococcal conjugate vaccine in Japan

Phase IIb topline results reported for cariprazine in bipolar depression

FDA grants orphan drug status to NHL treatments

Takeda licenses Trianni transgenic mouse antibody discovery platform

Eisai assigns Dacogen rights to Otsuka Pharmaceutical

Janssen Pharmaceutical discloses novel fatty acid synthase inhibitors

New MPS1 inhibitors presented by Cancer Research Technology

Japanese researchers design new MetAP 2 inhibitors

Reata Pharmaceuticals divulges new NO production inhibitors

Bristol-Myers Squibb presents new agent for thrombosis

New agents for dengue virus disclosed by SIGA Technologies

e-Therapeutics reports interim results from phase Ia trial of ETS-2101

CytRx's aldoxorubicin receives orphan medicinal product designation in Europe

GSK withdraws request for a variation to Votrient's marketing authorization

FDA lifts partial clinical hold on CUDC-427

Shire submits Intuniv MAA to EMA

NIH funds flavivirus research at The Scripps Research Institute

FDA advisory committee recommends approval of dalbavancin for ABSSSI

Tedizolid phosphate recommended for FDA approval for skin infections

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...